Dahlia Biosciences, Inc.
Biotechnology company · Orinda, California, United States
Dahlia Biosciences, Inc. is a biotechnology company headquartered in Orinda, California, United States. Its earliest recorded incorporation is in 2017. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $599,106 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $315,000 sold in a notice filed in 2018.
Dahlia Biosciences at a glance
What does Dahlia Biosciences do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $599,106 in total (2020 to 2021). NIH funding came from the National Human Genome Research Institute, National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $315,000 sold (2018).
Frequently asked questions about Dahlia Biosciences
Where is Dahlia Biosciences headquartered?
Dahlia Biosciences, Inc. is headquartered in Orinda, California, United States.
What does Dahlia Biosciences do?
Dahlia Biosciences, Inc. is a biotechnology company.
When was Dahlia Biosciences founded?
The earliest incorporation on record for Dahlia Biosciences, Inc. is in 2017, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences